Biotech Co. Wins $16.5M In Multiple Sclerosis Drug Fight
By Caroline Simson · October 17, 2022, 4:47 PM EDT
Acorda Therapeutics has been awarded $16.5 million by an arbitral panel following a dispute with Irish pharmaceutical company Alkermes over licensing royalties for the multiple sclerosis drug Ampyra, the New York-based...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login